作者
Amina Jindani, Thomas S Harrison, Andrew J Nunn, Patrick PJ Phillips, Gavin J Churchyard, Salome Charalambous, Mark Hatherill, Hennie Geldenhuys, Helen M McIlleron, Simbarashe P Zvada, Stanley Mungofa, Nasir A Shah, Simukai Zizhou, Lloyd Magweta, James Shepherd, Sambayawo Nyirenda, Janneke H Van Dijk, Heather E Clouting, David Coleman, Anna LE Bateson, Timothy D McHugh, Philip D Butcher, Denny A Mitchison
发表日期
2014/10/23
期刊
New England Journal of Medicine
卷号
371
期号
17
页码范围
1599-1608
出版商
Massachusetts Medical Society
简介
Background
Tuberculosis regimens that are shorter and simpler than the current 6-month daily regimen are needed.
Methods
We randomly assigned patients with newly diagnosed, smear-positive, drug-sensitive tuberculosis to one of three regimens: a control regimen that included 2 months of ethambutol, isoniazid, rifampicin, and pyrazinamide administered daily followed by 4 months of daily isoniazid and rifampicin; a 4-month regimen in which the isoniazid in the control regimen was replaced by moxifloxacin administered daily for 2 months followed by moxifloxacin and 900 mg of rifapentine administered twice weekly for 2 months; or a 6-month regimen in which isoniazid was replaced by daily moxifloxacin for 2 months followed by one weekly dose of both moxifloxacin and 1200 mg of rifapentine for 4 months. Sputum specimens were examined on microscopy and after culture at regular intervals. The primary …
引用总数
20142015201620172018201920202021202220232024373745760544543302816
学术搜索中的文章
A Jindani, TS Harrison, AJ Nunn, PPJ Phillips… - New England Journal of Medicine, 2014